Hansoh Pharma has established a comprehensive top-level supervisory framework for ESG governance. The company has set up a dedicated ESG Committee under the Board of Directors to integrate the concept of sustainable development deeply into its strategic planning system, coordinate the formulation of major ESG policies at the group level, and effectively guide the specific practices of each business unit. By regularly reporting to the Board on the progress of ESG policy implementation and the achievement of performance objectives, each business unit ensures a closed-loop management process from concept to practice.

To ensure the effectiveness of risk prevention and control, the company has built a risk monitoring mechanism independent of the business system, enabling forward-looking assessments of risks arising from policy changes, industry trends, and environmental factors. Through a top-down collaborative deployment mechanism, we continuously strengthen our risk management capabilities, providing solid support for the company’s sustainable development.

The company actively responds to climate change by quantifying its impacts, building a green R&D and production system, and developing eco-friendly processes. We strictly control carbon emissions across all operating sites and business activities. With firm actions and a consistent spirit of innovation, we work closely with stakeholders to play a role in addressing global climate change and contribute to enhancing the ecological value of the pharmaceutical industry.

Upholding a responsible attitude toward society and the environment, the company actively implements the concept of green development by continuously improving its environmental management system, strengthening the management of pollutants and waste, and enhancing the efficiency of energy and resource utilization. From the procurement of raw materials and excipients, through complex production processes, to product sales across the entire operational cycle, we strive to minimize negative environmental impacts and are devoted to building a resource-efficient and environmentally friendly enterprise.

The company actively practices the United Nations Sustainable Development Goal of “Good Health and Well-Being,” continuously exploring cutting-edge technologies worldwide and working hand in hand with global peers to continuously launch safer, more effective, and more affordable medicines that benefit human health. In line with international advanced standards, we have established a full life-cycle quality control and pharmacovigilance system. By providing rigorous and scientific academic services to medical institutions in a fair, transparent, and clear manner, we ensure the safety of patients’ medication.

As a pharmaceutical company committed to global health, we have a responsibility to improve human healthcare and contribute to the achievement of the United Nations Sustainable Development Goals. To this end, we continuously innovate and optimize our operations, leveraging knowledge, products, and services to provide patients worldwide with high-quality, affordable medicines, while also supporting community development and progress.